BridgeJIyengarSSalaryCB, Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. JAMA. 2007;297:1683–1696.
2.
HammadTALaughrenTRacoosinJ.Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006;63:332–339.
3.
LibbyABrentDAMorratoEH, Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry. 2007;164:884–891.
4.
OlfsonMShafferDMarcusSC, Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry. 2003;60:978–982.
5.
EmslieGKratochvilCVitielloB, Treatment for Adolescents with Depression Study (TADS): Safety results. J Am Acad Child Adolesc Psychiatry. 2006;45:1440–1455.
6.
The TADS Team. The Treatment for Adolescents with Depression Study (TADS): Long-term effectiveness and safety outcomes. Arch Gen Psychiatry. 2007;64:1132–1144.
7.
BrentDAEmslieGJClarkeGN, Switching to venlafaxine or another SSRI with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: The TORDIA randomized control trial. JAMA. 2008;299:901–913.
8.
RutzW.Mental health in Europe: Problems, advances and challenges. Acta Pedaetr Scand. 2001;410:15–20.
9.
OlfsonMMarcusSC. A case–control study of antidepressants and attempted suicide during early phase treatment of major depressive episodes. J Clin Psychiatry. 2008;69:425–432.
10.
SimonGESavarinoJOperskalskiB, Suicide risk during antidepressant treatment. Am J Psychiatry. 2006;163:41–47.